Fig. 23From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseChemical structures for 5-oxo-4,5-dihydropyrano coumarin derivativesBack to article page